Table IV.
Top 10 genes ranked by BC.
| Gene | BC | EXP | Degree | P-value | Qval | Qpval | τ2 |
|---|---|---|---|---|---|---|---|
| ESR1 | 4.03E−01 | − | 26 | 1.60E−02 | 2.73E+00 | 4.35E−01 | 0 |
| EP300 | 1.90E−01 | + | 19 | 4.86E−02 | 1.12E+00 | 7.73E−01 | 0 |
| TP53 | 6.70E−02 | Null | 10 | − | − | − | − |
| SMAD3 | 1.02E−01 | Null | 9 | − | − | − | − |
| EGFR | 7.40E−02 | Null | 9 | − | − | − | − |
| FN1 | 1.33E−01 | + | 8 | 9.80E−03 | 2.63E+00 | 4.52E−01 | 0 |
| SRC | 9.92E−02 | Null | 8 | − | − | − | − |
| PRKCA | 8.43E−02 | Null | 8 | − | − | − | − |
| DDX5 | 6.33E−02 | − | 8 | 1.00E−03 | 1.04E+00 | 7.91E−01 | 0 |
| EPOR | 2.35E−02 | + | 8 | 3.80E−02 | 6.93E−01 | 8.75E−01 | 0 |
'+' in the column 'EXP' indicates upregulation in metastatic OS, while '−' indicates downregulation and 'null' indicates no differential expression. BC, betweenness centrality; OS, osteosarcoma.